»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ÀÓ»ó½ÃÇè Áö¿ø ¼ºñ½º ½ÃÀåÀº 2024-2029³â 89¾ï 1,610¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 7.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ ÀÓ»ó½ÃÇè Áö¿ø ¼ºñ½º ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷ÀÇ ¼ºÀå, Àӻ󿬱¸¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, Áö¿ª ½ÃÀå¿¡¼ÀÇ ÀÓ»ó½ÃÇè ±ÔÁ¦ µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ
6.8%
CAGR
7.4%
Áõ°¡¾×
89¾ï 1,610¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³â µ¿¾È ÀÓ»ó½ÃÇè Áö¿ø ¼ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î Å©·Î½º ¼ö¿ä Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, Á¦¾à »ê¾÷À» ´ë»óÀ¸·Î ÇÑ ¿¬±¸ Áõ°¡¿Í e-ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð(2024³â)
½ÃÀå Àü¸Á(2024-2029³â)
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ÀÓ»ó½ÃÇè Áö¿ø ¼ºñ½º ½ÃÀå(2019-2023³â)
¿ëµµº° ºÎ¹® ºÐ¼®(2019-2023³â)
¿¬·ÉÃþº° ºÎ¹® ºÐ¼®(2019-2023³â)
Ä¡·á ¿µ¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ ÀÓ»ó½ÃÇè Áö¿ø ¼ºñ½º ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿ëµµº°
´Ü°è 2 : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
´Ü°è 3 : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
´Ü°è 1 : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
´Ü°è 4 : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ¿ëµµº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : ¿¬·ÉÃþº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿¬·ÉÃþº°
¼ºÀÎ(18¼¼ ÀÌ»ó) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
û¼Ò³â(10-18¼¼) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾î¸°ÀÌ(10¼¼ ¹Ì¸¸) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ¿¬·ÉÃþº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : Ä¡À¯ ¿µ¿ªº°
½ÃÀå ºÎ¹®
ºñ±³ : Ä¡À¯ ¿µ¿ªº°
Á¾¾çÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÉÀ庴ÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½Å°æÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
°¨¿°Áõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Ä¡À¯ ¿µ¿ªº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ºê¶óÁú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
ÆÄ±«Àû Çõ½Å »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
AH UK Holdco 1 Ltd.
Almac Group Ltd.
Catalent Inc.
Charles River Laboratories International Inc.
Eli Lilly and Co.
Eurofins Scientific SE
ICON plc
IQVIA Holdings Inc.
Laboratory Corp. of America Holdings
Parexel International Corp.
Pfizer Inc.
Quotient Sciences Ltd.
Syneos Health
Thermo Fisher Scientific Inc.
WuXi AppTec Co. Ltd.
Á¦16Àå ºÎ·Ï
LSH
The clinical trial support services market is forecasted to grow by USD 8,916.1 mn during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the clinical trial support services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of biopharmaceutical industry, government initiatives on clinical research, and regulation of clinical trials in regional markets.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 6.8%
CAGR 7.4%
Incremental Value $8,916.1 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's clinical trial support services market is segmented as below:
By Application
Phase 2
Phase 3
Phase 1
Phase 4
By Age Group
Adults (greater than 18 years)
Adolescents (10 to 18 years)
Children (less than 10 years)
By Therapeutic Area
Oncology
Cardiology
Neurology
Infectious diseases
Others
By Geographical Landscape
Europe
North America
Asia
Rest of World (ROW)
This study identifies the growing demand for cros as one of the prime reasons driving the clinical trial support services market growth during the next few years. Also, increase in studies focusing on pharmaceutical industry and rising demand for e-clinical trials will lead to sizable demand in the market.
The report on the clinical trial support services market covers the following areas:
Clinical Trial Support Services Market sizing
Clinical Trial Support Services Market forecast
Clinical Trial Support Services Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial support services market vendors that include AH UK Holdco 1 Ltd., Almac Group Ltd., Brighter Health Network LLC, Catalent Inc., Charles River Laboratories International Inc., Clinipace Inc., Eli Lilly and Co., Eurofins Scientific SE, ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, MARKEN Ltd., Parexel International Corp., Pfizer Inc., Quotient Sciences Ltd., Seveillar Clinical Supplies Services Pvt. Ltd., Syneos Health, Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.. Also, the clinical trial support services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Age Group
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Clinical Trial Support Services Market 2019 - 2023
Historic Market Size - Data Table on Global Clinical Trial Support Services Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Age Group segment analysis 2019 - 2023
Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
5.4 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The impact of AI in the global clinical trial support services market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Phase 2 - Market size and forecast 2024-2029
Chart on Phase 2 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 2 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 2 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 2 - Year-over-year growth 2024-2029 (%)
8.4 Phase 3 - Market size and forecast 2024-2029
Chart on Phase 3 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 3 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 3 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 3 - Year-over-year growth 2024-2029 (%)
8.5 Phase 1 - Market size and forecast 2024-2029
Chart on Phase 1 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 1 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 1 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 1 - Year-over-year growth 2024-2029 (%)
8.6 Phase 4 - Market size and forecast 2024-2029
Chart on Phase 4 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 4 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 4 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 4 - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Age Group
9.1 Market segments
Chart on Age Group - Market share 2024-2029 (%)
Data Table on Age Group - Market share 2024-2029 (%)
9.2 Comparison by Age Group
Chart on Comparison by Age Group
Data Table on Comparison by Age Group
9.3 Adults (greater than 18 years) - Market size and forecast 2024-2029
Chart on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
Data Table on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
Chart on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
Data Table on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
9.4 Adolescents (10 to 18 years) - Market size and forecast 2024-2029
Chart on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
Data Table on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
Chart on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
Data Table on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
9.5 Children (less than 10 years) - Market size and forecast 2024-2029
Chart on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
Data Table on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
Chart on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
Data Table on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Age Group
Market opportunity by Age Group ($ million)
Data Table on Market opportunity by Age Group ($ million)
10 Market Segmentation by Therapeutic Area
10.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
10.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
10.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Cardiology - Market size and forecast 2024-2029
Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
10.5 Neurology - Market size and forecast 2024-2029
Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)
10.6 Infectious diseases - Market size and forecast 2024-2029
Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
10.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.4 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AH UK Holdco 1 Ltd.
AH UK Holdco 1 Ltd. - Overview
AH UK Holdco 1 Ltd. - Product / Service
AH UK Holdco 1 Ltd. - Key offerings
SWOT
15.5 Almac Group Ltd.
Almac Group Ltd. - Overview
Almac Group Ltd. - Product / Service
Almac Group Ltd. - Key offerings
SWOT
15.6 Catalent Inc.
Catalent Inc. - Overview
Catalent Inc. - Business segments
Catalent Inc. - Key offerings
Catalent Inc. - Segment focus
SWOT
15.7 Charles River Laboratories International Inc.
Charles River Laboratories International Inc. - Overview
Charles River Laboratories International Inc. - Business segments
Charles River Laboratories International Inc. - Key offerings
Charles River Laboratories International Inc. - Segment focus
SWOT
15.8 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
15.9 Eurofins Scientific SE
Eurofins Scientific SE - Overview
Eurofins Scientific SE - Business segments
Eurofins Scientific SE - Key offerings
Eurofins Scientific SE - Segment focus
SWOT
15.10 ICON plc
ICON plc - Overview
ICON plc - Product / Service
ICON plc - Key offerings
SWOT
15.11 IQVIA Holdings Inc.
IQVIA Holdings Inc. - Overview
IQVIA Holdings Inc. - Business segments
IQVIA Holdings Inc. - Key offerings
IQVIA Holdings Inc. - Segment focus
SWOT
15.12 Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings - Overview
Laboratory Corp. of America Holdings - Business segments
Laboratory Corp. of America Holdings - Key news
Laboratory Corp. of America Holdings - Key offerings
Laboratory Corp. of America Holdings - Segment focus
SWOT
15.13 Parexel International Corp.
Parexel International Corp. - Overview
Parexel International Corp. - Product / Service
Parexel International Corp. - Key offerings
SWOT
15.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.15 Quotient Sciences Ltd.
Quotient Sciences Ltd. - Overview
Quotient Sciences Ltd. - Product / Service
Quotient Sciences Ltd. - Key offerings
SWOT
15.16 Syneos Health
Syneos Health - Overview
Syneos Health - Product / Service
Syneos Health - Key offerings
SWOT
15.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
15.18 WuXi AppTec Co. Ltd.
WuXi AppTec Co. Ltd. - Overview
WuXi AppTec Co. Ltd. - Business segments
WuXi AppTec Co. Ltd. - Key offerings
WuXi AppTec Co. Ltd. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations